5-Lipoxygenase
5-Lipoxygenase(5-脂氧合酶)
5-lipoxygenase catalyzes oxidation of AA at the 5-position to yield 5-HpETE and is a current target for pharmaceutical intervention in a number of diseases such as asthma, atherosclerosis and several cancers.
5-Lipoxygenase 相关产品(10)
- GC12232BAY-X 1005CAS: 128253-31-6纯度: >98.50%
BAY-X 1005 (BAY X 1005; DG-031) 是一种具有口服活性的选择性 5-脂氧合酶活化蛋白 (FLAP) 抑制剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10451 | U-73122 | 112648-68-7 | >98.00% | |
U-73122是有效的、选择性的磷脂酶C(PLC)抑制剂,IC 50 值约为1-2.1μM,也可抑制5-脂氧合酶(5-LO)。 | ||||
| GC14435 | Zileuton sodium | 118569-21-4 | - | |
A reversible inhibitor of 5-lipoxygenase | ||||
| GC14751 | Malotilate | 59937-28-9 | >99.50% | |
A hepatoprotective agent | ||||
| GC16014 | Zileuton | 111406-87-2 | >99.00% | |
Zileuton是一种苯并噻吩N-羟基脲类化合物,作为口服5-脂氧合酶抑制剂。 | ||||
| GC10709 | BW-B 70C | 134470-38-5 | - | |
BW-B 70C 是一种有效的、选择性的和具有口服活性的花生四烯酸 5-脂氧合酶抑制剂。 | ||||
| GC12205 | PD 146176 | 4079-26-9 | >98.00% | |
PD 146176 是一种有效的选择性网织红细胞 15-LOX-1 抑制剂。 | ||||
| GC12232 | BAY-X 1005 | 128253-31-6 | >98.50% | |
BAY-X 1005 (BAY X 1005; DG-031) 是一种具有口服活性的选择性 5-脂氧合酶活化蛋白 (FLAP) 抑制剂。 | ||||
| GC12277 | MK 886 | 118414-82-7 | >99.50% | |
A potent, selective inhibitor of FLAP | ||||
| GC15961 | β-acetyl-Boswellic Acid | 5968-70-7 | - | |
An anti-inflammatory pentacyclic triterpene | ||||
| GC17951 | 2-TEDC | 132465-10-2 | - | |
5-, 12-, and 15-lipoxygenase inhibitor | ||||
